Cabozantinib (C) plus atezolizumab (A) or C alone in patients (pts) with advanced non–small cell lung cancer (aNSCLC) previously treated with an immune checkpoint inhibitor (ICI): Results from Cohorts ...

This fund does not subscribe to Trustnet. Trustnet looks at the latest changes to the premier UK index following the latest reshuffle by FTSE Russell.

This fund does not subscribe to Trustnet. FE fundinfo data reveals how Japanese and Korean equities surged to the top of the performance tables in February.

This investment trust can be held in an Investment ISA, SIPP and Investment Account Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge.